NewAmsterdam Pharma (NAMS) Accounts Payables (2021 - 2026)
NewAmsterdam Pharma (NAMS) recorded Accounts Payables of $10.28 million in Q2 2026, up 8.6% from $9.46 million a year earlier and up 27.0% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Accounts Payables (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma reported Accounts Payables of $15.42 million, up 13.3% from FY2024.
- Annual Accounts Payables has a four-year compound annual growth rate of 7.3% (FY2021 to FY2025).
- Across earlier years, Accounts Payables came in at $13.61 million in FY2024 (-19.6%), $16.92 million in FY2023 (+42.8%), $11.85 million in FY2022 (+1.9%) and $11.63 million in FY2021.
- Quarterly Accounts Payables has ranged from $8.02 million in Q1 2025 to $22.71 million in Q2 2023 over the past five years.
- On a year-over-year basis, Accounts Payables has increased for three consecutive quarters, with an average decline of 4.0% over the last seven quarters.
- Peak year-over-year performance for Accounts Payables in the last five years was growth of 67.9% in Q4 2022, against a decline of 55.1% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.09 million (Q1 2026), $15.42 million (Q4 2025) and $10.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | NewAmsterdam Pharma | 2.86 Bn | 2.86 Bn | - | 10.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.28 Mn |
| Mar 31, 2026 | 8.09 Mn |
| Dec 31, 2025 | 15.42 Mn |
| Sep 30, 2025 | 10.10 Mn |
| Jun 30, 2025 | 9.46 Mn |
| Mar 31, 2025 | 8.02 Mn |
| Dec 31, 2024 | 13.61 Mn |
| Sep 30, 2024 | 10.58 Mn |
| Jun 30, 2024 | 10.19 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 16.92 Mn |
| Jun 30, 2023 | 22.71 Mn |
| Dec 31, 2022 | 18.88 Mn |
| Dec 31, 2021 | 11.24 Mn |
API Access
NewAmsterdam Pharma Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();